Cargando…
The structure and characterization of human cytochrome P450 8B1 supports future drug design for nonalcoholic fatty liver disease and diabetes
Human cytochrome P450 8B1 (CYP8B1) is involved in conversion of cholesterol to bile acids. It hydroxylates the steroid ring at C12 to ultimately produce the bile acid cholic acid. Studies implicated this enzyme as a good drug target for nonalcoholic fatty liver disease and type 2 diabetes, but there...
Autores principales: | Liu, Jinghan, Carlson, Heather A., Scott, Emily E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463588/ https://www.ncbi.nlm.nih.gov/pubmed/35944583 http://dx.doi.org/10.1016/j.jbc.2022.102344 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes
por: Jamwal, Rohitash, et al.
Publicado: (2020) -
Pyridine-containing substrate analogs are restricted from accessing the human cytochrome P450 8B1 active site by tryptophan 281
por: Liu, Jinghan, et al.
Publicado: (2023) -
Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain
por: Burris-Hiday, Sarah D., et al.
Publicado: (2023) -
Effects of Short- and Long-Term Soy Protein Feeding on Hepatic Cytochrome P450 Expression in Obese Nonalcoholic Fatty Liver Disease Rat Model
por: Kozaczek, Melisa, et al.
Publicado: (2021) -
Human cytochrome P450 3A7 binding four copies of its native substrate dehydroepiandrosterone 3-sulfate
por: Liu, Jinghan, et al.
Publicado: (2023)